Milestone Pharmaceuticals Inc. Common Shares Profile
About
Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr?al, Canada.
Info & Links
CEO
Joseph Oliveto
Headquarters
1111 DR. FREDERIK-PHILIPS BOULEVARD, SUITE 420 MONTREAL, A8 H4M 2X6, CANADA
Milestone Pharmaceuticals Inc. Common Shares Statistics
Valuation Measures
Market Capitalization2
47.38M
Enterprise Value
75.42M
Enterprise Value/EBITDA(ttm)
-1.80
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
4.57
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-151.82%
Return on Invested Capital(ttm)
-53.58%
Return on Assets(ttm)
-49.85%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-42.00M
Net Income Available to Common(ttm)
-41.52M
Diluted EPS(ttm)
-0.81
Share Statistics
Beta (5Y Monthly)
1.80
52-Week Change
-49.03%
S&P 500 52-Week Change
6.35%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
53.35M
Dividend Yield
0.00%
Float4
48.05M
% Held by Insiders
9.90%
% Held by Institutions
86.18%
Balance Sheet
Total Cash(mrq)
69.69M
Total Cash Per Share(mrq)
1.31
Total Debt(mrq)
53.35M
Total Debt/Equity(mrq)
405.81%
Current Ratio(mrq)
9.10%
Quick Ratio(mrq)
15.40%
Book Value Per Share(mrq)
0.25
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.46
Free Cash Flow(ytd)
-28.88M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.